2BB score and signals
NRX Pharmaceuticals, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 36 | Low |
| Momentum | 54 | Stable |
| Financial strength | 4 | Very Weak |
| Quality | 54 | Normal |
| Risk | 79 | High |
Company facts
| Headquarters | Wilmington, Delaware, United States |
| Founded | 2015 |
| Employees | 29 |
| 52-week range | $1.62 – $5.06 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-22 | — | 0.0082 | — | $22.49M |
| 2026-11-16 | — | -0.0143 | — | $17.58M |
| 2026-08-17 | — | 0.0653 | — | $16.89M |
| 2026-05-15 | -0.04 | 0.2932 | $1.07M | $26.08M |
Related companies
